BRIPLATIN Side Effects

7012481-8 | Subileus
on Sep 22, 2010 Female patient from JAPAN , 60 years of age, weighting 103.6 lb, was diagnosed with cervix carcinoma recurrent and was treated with Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: subileus. Briplatin dosage: . During the same period patient was treated with S 1 (View S-1 Review and S-1 Label ).

7002455-5 | Disseminated Intravascular Coagulation, Leukaemia, Myelodysplastic Syndrome
Patient was taking Briplatin (View Usage). Patient had the following side effects: disseminated intravascular coagulation, leukaemia, myelodysplastic syndrome on Sep 15, 2010 from JAPAN Additional patient health information: Male patient , 36 years of age, . Briplatin dosage: Dose 1: 5 Cycles Dose 2: 1 Cycle.from Apr09-ongoing. During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ), IRINOTECAN HCL (Also Start On Jun09 Once Weekly.inj) (View Irinotecan Hcl Review and Irinotecan Hcl Label ).

6939184-X | Gastrointestinal Haemorrhage, Pancreatic Pseudocyst, Pancreatitis, Pancytopenia
Adverse event was reported on Aug 16, 2010 by a Female patient taking Briplatin (View Usage) (Dosage: ) was diagnosed with gastric cancer and. Location: JAPAN , 63 years of age, After Briplatin was administered, patient had the following side effects: gastrointestinal haemorrhage, pancreatic pseudocyst, pancreatitis, pancytopenia. During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ). Patient was hospitalized.

6922743-8 | Subileus
on Aug 11, 2010 Female patient from JAPAN , 60 years of age, weighting 103.6 lb, was diagnosed with cervix carcinoma recurrent and was treated with Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: subileus. Briplatin dosage: . During the same period patient was treated with S 1 (View S-1 Review and S-1 Label ).


6909058-9 | Deep Vein Thrombosis
on Aug 03, 2010 Female patient from JAPAN , 66 years of age, weighting 112.4 lb, was diagnosed with cervix carcinoma, gastritis, back pain (What is back pain?), constipation (What is constipation?), prophylaxis, insomnia and was treated with Briplatin (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Briplatin dosage: Cycle 4:60mg On 13mar2010 Dropped Out On 08jun2010. During the same period patient was treated with S 1 (Cycle 4:120mg On 13may10-26may10 Dropped Out On 08jun2010) (View S-1 Review and S-1 Label ), SELBEX (View Selbex Review and Selbex Label ), LORCAM (Tabs) (View Lorcam Review and Lorcam Label ), PURSENNID (Tabs) (View Pursennid Review and Pursennid Label ), JUZEN TAIHO TO (View Juzen-taiho-to Review and Juzen-taiho-to Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), EURODIN (View Eurodin Review and Eurodin Label ). Patient was hospitalized.

6881474-3 | Deep Vein Thrombosis
Patient was taking Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?) on Jul 26, 2010 from JAPAN Additional patient health information: Female patient , 66 years of age, weighting 112.4 lb, was diagnosed with cervix carcinoma, gastritis, back pain (What is back pain?), constipation (What is constipation?), prophylaxis, insomnia and. Briplatin dosage: Cycle 4:60mg On 13mar2010 Dropped Out On 08jun2010. During the same period patient was treated with S 1 (Cycle 4:120mg On 13may10-26may10 Dropped Out On 08jun2010) (View S-1 Review and S-1 Label ), SELBEX (View Selbex Review and Selbex Label ), LORCAM (Tabs) (View Lorcam Review and Lorcam Label ), PURSENNID (Tabs) (View Pursennid Review and Pursennid Label ), JUZEN TAIHO TO (View Juzen-taiho-to Review and Juzen-taiho-to Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), EURODIN (View Eurodin Review and Eurodin Label ). Patient was hospitalized.

6844724-5 | Deep Vein Thrombosis
Adverse event was reported on Jul 13, 2010 by a Female patient taking Briplatin (View Usage) (Dosage: Cycle 4:60mg On 13mar2010 Dropped Out On 08jun2010) was diagnosed with cervix carcinoma, gastritis, back pain (What is back pain?), constipation (What is constipation?), prophylaxis, insomnia and. Location: JAPAN , 66 years of age, weighting 112.4 lb, Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). During the same period patient was treated with S 1 (Cycle 4:120mg On 13may10-26may10 Dropped Out On 08jun2010) (View S-1 Review and S-1 Label ), SELBEX (View Selbex Review and Selbex Label ), LORCAM (Tabs) (View Lorcam Review and Lorcam Label ), PURSENNID (Tabs) (View Pursennid Review and Pursennid Label ), JUZEN TAIHO TO (View Juzen-taiho-to Review and Juzen-taiho-to Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), EURODIN (View Eurodin Review and Eurodin Label ). Patient was hospitalized.

6823125-X | Subileus
on Jul 05, 2010 Female patient from JAPAN , 60 years of age, weighting 103.6 lb, was diagnosed with cervix carcinoma recurrent and was treated with Briplatin (View Usage). Patient had the following side effects: subileus. Briplatin dosage: . During the same period patient was treated with S 1 (View S-1 Review and S-1 Label ).

6814409-X | Dehydration, Nausea
on Jun 25, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with oesophageal carcinoma and was treated with Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: dehydration, nausea (What is nausea?). Briplatin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), AMRUBICIN HCL (View Amrubicin Hcl Review and Amrubicin Hcl Label ), IRINOTECAN HCL (Form=inj) (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

6766633-2 | Deep Vein Thrombosis
Patient was taking Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?) on Jun 09, 2010 from JAPAN Additional patient health information: Female patient , 66 years of age, was diagnosed with cervix carcinoma and. Briplatin dosage: Cycle 4:60mg On 19mar2010 Dropped Out On 08jun2010. During the same period patient was treated with S 1 (Cycle 4:120mg On 13may10-26may10 Dropped Out On 08jun2010) (View S-1 Review and S-1 Label ). Patient was hospitalized.

6762038-9 | Subileus
Adverse event was reported on Jun 07, 2010 by a Female patient taking Briplatin (View Usage) (Dosage: ) was diagnosed with cervix carcinoma recurrent and. Location: JAPAN , 60 years of age, weighting 103.6 lb, Patient had the following side effects: subileus. During the same period patient was treated with S 1 (View S-1 Review and S-1 Label ). Patient was hospitalized.

6751147-6 | Abdominal Pain, Erythema, Productive Cough, Pyrexia, Rash
on May 27, 2010 Male patient from JAPAN , 69 years of age, weighting 143.3 lb, was diagnosed with lung neoplasm malignant and was treated with Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), erythema, productive cough, pyrexia, rash (What is rash?). Briplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), IRINOTECAN HCL (Inj) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), ZOLPIDEM TARTRATE (Tabs) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ITOPRIDE HCL (Tabs) (View Itopride Hcl Review and Itopride Hcl Label ), CANDESARTAN CILEXETIL (Tabs) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), DEXAMETHASONE (Tabs) (View Dexamethasone Review and Dexamethasone Label ), LEVOFLOXACIN (Hydrate;tabs) (View Levofloxacin Review and Levofloxacin Label ), TRICHLORMETHIAZIDE (Tabs) (View Trichlormethiazide Review and Trichlormethiazide Label ).

6733811-8 | Abdominal Pain Upper
on May 17, 2010 Female patient from JAPAN , 60 years of age, weighting 103.6 lb, was diagnosed with cervix carcinoma recurrent and was treated with Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper. Briplatin dosage: . During the same period patient was treated with S 1 (View S-1 Review and S-1 Label ). Patient was hospitalized.

6709873-0 | Abdominal Pain Upper
Patient was taking Briplatin (View Usage). Patient had the following side effects: abdominal pain upper on Apr 30, 2010 from JAPAN Additional patient health information: Female patient , 47 years of age, weighting 101.4 lb, was diagnosed with cervix carcinoma recurrent and. Briplatin dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), MAGMITT (Tab) (View Magmitt Review and Magmitt Label ), ALOSENN (View Alosenn Review and Alosenn Label ), SELBEX (View Selbex Review and Selbex Label ), INCREMIN (View Incremin Review and Incremin Label ), RHYTHMY (View Rhythmy Review and Rhythmy Label ). Patient was hospitalized.

6694548-7 | Abdominal Pain Upper
Adverse event was reported on Apr 21, 2010 by a Female patient taking Briplatin (View Usage) (Dosage: ) was diagnosed with cervix carcinoma recurrent and. Location: JAPAN , 47 years of age, weighting 101.4 lb, After Briplatin was administered, patient had the following side effects: abdominal pain upper. During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), MAGMITT (Tab) (View Magmitt Review and Magmitt Label ), ALOSENN (View Alosenn Review and Alosenn Label ), SELBEX (View Selbex Review and Selbex Label ), INCREMIN (View Incremin Review and Incremin Label ), RHYTHMY (View Rhythmy Review and Rhythmy Label ). Patient was hospitalized.

6686121-1 | Abdominal Pain Upper
on Apr 15, 2010 Female patient from JAPAN , 47 years of age, weighting 101.4 lb, was diagnosed with cervix carcinoma recurrent and was treated with Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper. Briplatin dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), MAGMITT (Tab) (View Magmitt Review and Magmitt Label ), ALOSENN (View Alosenn Review and Alosenn Label ), SELBEX (View Selbex Review and Selbex Label ), INCREMIN (View Incremin Review and Incremin Label ), RHYTHMY (View Rhythmy Review and Rhythmy Label ). Patient was hospitalized.

6672562-5 | Ileus
on Apr 01, 2010 Female patient from JAPAN , 36 years of age, weighting 97.00 lb, was diagnosed with cervix carcinoma, peripheral sensory neuropathy, constipation prophylaxis, prophylaxis of nausea and vomiting and was treated with Briplatin (View Usage). Patient had the following side effects: ileus. Briplatin dosage: 1st Cycle:28july09 2nd Cycle:18aug09. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), OXINORM (View Oxinorm Review and Oxinorm Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), LAC B (View Lac-b Review and Lac-b Label ), EVAMYL (View Evamyl Review and Evamyl Label ), DAI KENCHU TO (Dai-kenchu-to Extract) (View Dai-kenchu-to Review and Dai-kenchu-to Label ), PRIMPERAN INJ (Primperan Tablets 5) (View Primperan Inj Review and Primperan Inj Label ). Patient was hospitalized.

6665167-3 | Abdominal Pain
Patient was taking Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?) on Mar 24, 2010 from JAPAN Additional patient health information: Male patient , 52 years of age, was diagnosed with gastric cancer and. Briplatin dosage: On Day 1 Every 5 Weeks. During the same period patient was treated with TS 1 (Day 1-21 Every 5 Weeks) (View Ts-1 Review and Ts-1 Label ), TAXOTERE (Inj Leve1/2/3:20/25/30 Mg/m2 On Day 1,8 And 15 Every 5 Weeks Level4:40mg/m2 From Day 1-15.) (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6653191-6 | Abdominal Pain, Erythema, Productive Cough, Pyrexia, Rash
Adverse event was reported on Mar 15, 2010 by a Male patient taking Briplatin (View Usage) (Dosage: ) was diagnosed with lung neoplasm malignant and. Location: JAPAN , 69 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), erythema, productive cough, pyrexia, rash (What is rash?). During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), IRINOTECAN HCL (Inj) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), ZOLPIDEM TARTRATE (Tabs) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ITOPRIDE HCL (Tabs) (View Itopride Hcl Review and Itopride Hcl Label ), CANDESARTAN CILEXETIL (Tabs) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), DEXAMETHASONE (Tabs) (View Dexamethasone Review and Dexamethasone Label ), LEVOFLOXACIN (Hydrate;tabs) (View Levofloxacin Review and Levofloxacin Label ), TRICHLORMETHIAZIDE (Tabs) (View Trichlormethiazide Review and Trichlormethiazide Label ).

6592606-9 | Pneumonitis
on Feb 08, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Briplatin (View Usage). Patient had the following side effects: pneumonitis. Briplatin dosage: . During the same period patient was treated with VINORELBINE (Inj) (View Vinorelbine Review and Vinorelbine Label ).

6541021-2 | Ileus
on Jan 12, 2010 Female patient from JAPAN , 36 years of age, weighting 97.00 lb, was diagnosed with cervix carcinoma, peripheral sensory neuropathy, constipation prophylaxis, prophylaxis of nausea and vomiting and was treated with Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: ileus. Briplatin dosage: . During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), OXINORM (View Oxinorm Review and Oxinorm Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), LAC B (View Lac-b Review and Lac-b Label ), EVAMYL (View Evamyl Review and Evamyl Label ), DAI KENCHU TO (Dai-kenchu-to Extract) (View Dai-kenchu-to Review and Dai-kenchu-to Label ), PRIMPERAN TAB (Primperan Tablets 5) (View Primperan Tab Review and Primperan Tab Label ). Patient was hospitalized.

6525661-2 | Ileus
Patient was taking Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: ileus on Dec 28, 2009 from JAPAN Additional patient health information: Female patient , 36 years of age, weighting 97.00 lb, was diagnosed with cervix carcinoma, peripheral sensory neuropathy, constipation prophylaxis, prophylaxis of nausea and vomiting and. Briplatin dosage: . During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), OXINORM (View Oxinorm Review and Oxinorm Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), LAC B (View Lac-b Review and Lac-b Label ), EVAMYL (View Evamyl Review and Evamyl Label ), DAI KENCHU TO (Dai-kenchu-to Extract) (View Dai-kenchu-to Review and Dai-kenchu-to Label ), PRIMPERAN TAB (Primperan Tablets 5) (View Primperan Tab Review and Primperan Tab Label ). Patient was hospitalized.

6497503-5 | Diabetes Insipidus, Pancytopenia, Renal Impairment
Adverse event was reported on Dec 04, 2009 by a Male patient taking Briplatin (View Usage) (Dosage: ) was diagnosed with germ cell cancer and. Location: JAPAN , child 11 years of age, Patient had the following side effects: diabetes insipidus (What is diabetes insipidus?), pancytopenia, renal impairment. During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ), IFOSFAMIDE (Formulation: Inj) (View Ifosfamide Review and Ifosfamide Label ).

6459130-5 | Hyponatraemia
on Nov 19, 2009 Female patient from JAPAN , 54 years of age, weighting 81.57 lb, was diagnosed with cervix carcinoma, prophylaxis of nausea and vomiting, urine output increased and was treated with Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: hyponatraemia. Briplatin dosage: 52 Mg Once Weekly. During the same period patient was treated with GRANISETRON HCL (Inj) (View Granisetron Hcl Review and Granisetron Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6449238-2 | Teratoma
on Nov 10, 2009 Female patient from JAPAN , 33 years of age, was diagnosed with ovarian cancer and was treated with Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: teratoma. Briplatin dosage: . During the same period patient was treated with VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), PEPLOMYCIN SULFATE (View Peplomycin Sulfate Review and Peplomycin Sulfate Label ).

6438100-7 | Oesophageal Stenosis
Patient was taking Briplatin (View Usage). Patient had the following side effects: oesophageal stenosis on Nov 04, 2009 from JAPAN Additional patient health information: Male patient , 14 years of age, was diagnosed with bone sarcoma and. Briplatin dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), IFOSFAMIDE (Inj.2,6 Courses.) (View Ifosfamide Review and Ifosfamide Label ), LASTET (2,6 Courses) (View Lastet Review and Lastet Label ). Patient was hospitalized.

6406035-1 | Ileus
Adverse event was reported on Oct 15, 2009 by a Female patient taking Briplatin (View Usage) (Dosage: ) was diagnosed with cervix carcinoma and. Location: JAPAN , 36 years of age, weighting 97.00 lb, After Briplatin was administered, patient had the following side effects: ileus. Patient was hospitalized.

6342878-0 | Ileus
on Sep 01, 2009 Female patient from JAPAN , 36 years of age, weighting 97.00 lb, was diagnosed with cervix carcinoma and was treated with Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: ileus. Briplatin dosage: . Patient was hospitalized.

6337717-8 | Ileus
on Aug 28, 2009 Female patient from JAPAN , 36 years of age, weighting 97.00 lb, was diagnosed with cervix carcinoma and was treated with Briplatin (View Usage). Patient had the following side effects: ileus. Briplatin dosage: . Patient was hospitalized.

6177621-1 | Cerebral Infarction, Diarrhoea, Nausea
Patient was taking Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: cerebral infarction, diarrhoea, nausea (What is nausea?) on Apr 30, 2009 from JAPAN Additional patient health information: Male patient , 31 years of age, was diagnosed with testis cancer and. Briplatin dosage: 3 Courses Administered.. During the same period patient was treated with VEPESID (3 Courses Administered.) (View Vepesid Review and Vepesid Label ), BLEO (3 Courses Administered.) (View Bleo Review and Bleo Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ).

6163872-9 | Acute Respiratory Failure, Anorexia, Blood Bilirubin Increased, Blood Creatinine Increased, Blood Hyposmosis, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, C-reactive Protein Increased, Constipation
Adverse event was reported on Apr 15, 2009 by a Male patient taking Briplatin (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: JAPAN , 68 years of age, Patient experienced the following unwanted or unexpected effects: acute respiratory failure, anorexia, blood bilirubin increased, blood creatinine increased, blood hyposmosis, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, constipation (What is constipation?). During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), EPADEL (View Epadel Review and Epadel Label ), NOLEPTAN (View Noleptan Review and Noleptan Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), CEFZON (View Cefzon Review and Cefzon Label ), ADONA (View Adona Review and Adona Label ), TRANSAMIN (View Transamin Review and Transamin Label ). Patient was hospitalized.

6119887-X | Rhabdomyosarcoma
on Mar 11, 2009 Female patient from JAPAN , 14 years of age, was diagnosed with bone sarcoma and was treated with Briplatin (View Usage). Patient had the following side effects: rhabdomyosarcoma. Briplatin dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), ADRIAMYCIN RDF (View Adriamycin Rdf Review and Adriamycin Rdf Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PEPLEO (View Pepleo Review and Pepleo Label ).

6104024-8 | Cerebral Infarction, Diarrhoea
on Feb 27, 2009 Male patient from JAPAN , 31 years of age, was diagnosed with testis cancer and was treated with Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: cerebral infarction, diarrhoea. Briplatin dosage: . During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ), BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ).

6091227-4 | Disseminated Intravascular Coagulation, Sepsis, White Blood Cell Count Decreased
Patient was taking Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, sepsis (What is sepsis?), white blood cell count decreased on Feb 20, 2009 from JAPAN Additional patient health information: Male patient , 41 years of age, . Briplatin dosage: On Day 1. During the same period patient was treated with FLUOROURACIL (Day 1-5) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6083620-0 | Bone Marrow Failure, Duodenal Perforation, Oedema Peripheral
Adverse event was reported on Feb 13, 2009 by a Female patient taking Briplatin (View Usage) (Dosage: ) was diagnosed with squamous cell carcinoma and. Location: JAPAN , 54 years of age, Patient had the following side effects: bone marrow failure, duodenal perforation, oedema peripheral. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6052744-6 | Glomerulonephropathy, Intestinal Perforation, Pulmonary Tuberculosis, Sepsis, Tumour Lysis Syndrome
on Jan 21, 2009 Male patient from JAPAN , 59 years of age, was diagnosed with gastric cancer and was treated with Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: glomerulonephropathy, intestinal perforation, pulmonary tuberculosis, sepsis (What is sepsis?), tumour lysis syndrome. Briplatin dosage: . During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

6043934-7 | Haemolytic Uraemic Syndrome
on Jan 14, 2009 Female patient from JAPAN , 67 years of age, was diagnosed with bladder transitional cell carcinoma and was treated with Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic uraemic syndrome. Briplatin dosage: . During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

5975803-2 | Cardio-respiratory Arrest, Diarrhoea, Hyponatraemia, Renal Disorder
Patient was taking Briplatin (View Usage). Patient had the following side effects: cardio-respiratory arrest, diarrhoea, hyponatraemia, renal disorder on Nov 27, 2008 from JAPAN Additional patient health information: Male patient , 72 years of age, was diagnosed with oesophageal carcinoma and. Briplatin dosage: Initiated On 19may03,40mg/m2. During the same period patient was treated with FLUOROURACIL (Initiated On 19may03,400mg/m2 On Day 1-5) (View Fluorouracil Review and Fluorouracil Label ).

5923351-8 | Cytomegalovirus Gastroenteritis, Paraneoplastic Pemphigus, Septic Shock, Shock Haemorrhagic
Adverse event was reported on Oct 14, 2008 by a Male patient taking Briplatin (View Usage) (Dosage: ) was diagnosed with oesophageal carcinoma and. Location: JAPAN , 58 years of age, After Briplatin was administered, patient had the following side effects: cytomegalovirus gastroenteritis, paraneoplastic pemphigus, septic shock, shock haemorrhagic. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

5908459-5 | Anorexia, Ascites, Diarrhoea, Febrile Neutropenia, Hypoalbuminaemia, Oedema Peripheral
on Oct 02, 2008 Female patient from JAPAN , 53 years of age, was diagnosed with lung adenocarcinoma, lung neoplasm malignant and was treated with Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, ascites, diarrhoea, febrile neutropenia, hypoalbuminaemia, oedema peripheral. Briplatin dosage: Cyc1:30jan08(initiated 80%) Cyc2:21feb08(80%) Cyc3:2apr08 Cyc4:30apr08. During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), NAVELBINE (Initiated On 30-jan-2008, Also Recieved On 21-feb-2008.) (View Navelbine Review and Navelbine Label ). Patient was hospitalized.

5887853-5 | Angina Pectoris, Hypertension
on Sep 17, 2008 Male patient from JAPAN , 31 years of age, was diagnosed with testis cancer and was treated with Briplatin (View Usage). Patient had the following side effects: angina pectoris, hypertension. Briplatin dosage: . During the same period patient was treated with PARAPLATIN (View Paraplatin Review and Paraplatin Label ), VEPESID (1600~2400mg/m2,1/1day,4d) (View Vepesid Review and Vepesid Label ), IFOMIDE (6000~10000mg/m2,1/1day,duration 4 Days) (View Ifomide Review and Ifomide Label ), BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ).

5883849-8 | Anorexia, Ascites, Diarrhoea, Febrile Neutropenia, Hypoalbuminaemia, Oedema Peripheral
Patient was taking Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: anorexia, ascites, diarrhoea, febrile neutropenia, hypoalbuminaemia, oedema peripheral on Sep 09, 2008 from JAPAN Additional patient health information: Female patient , 53 years of age, was diagnosed with lung adenocarcinoma, lung neoplasm malignant and. Briplatin dosage: Cyc1:30jan08(initiated 80%) Cyc2:21feb08(80%) Cyc3:2apr08 Cyc4:30apr08. During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), NAVELBINE (Initiated On 30-jan-2008, Also Recieved On 21-feb-2008.) (View Navelbine Review and Navelbine Label ). Patient was hospitalized.

5873138-X | Acute Myocardial Infarction, Prinzmetal Angina, Pulmonary Infarction
Adverse event was reported on Sep 02, 2008 by a Male patient taking Briplatin (View Usage) (Dosage: Had Also Received From Aug-2003 To Mar-2004 And Aug-2004 To Nov-2004 Without Adverse Reactions.) was diagnosed with hepatic cancer metastatic and. Location: JAPAN , 58 years of age, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, prinzmetal angina, pulmonary infarction. During the same period patient was treated with MITOMYCIN (View Mitomycin Review and Mitomycin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), GANATON (View Ganaton Review and Ganaton Label ), NAIXAN (View Naixan Review and Naixan Label ). Patient was hospitalized.

5871317-9 | Anaemia, Anorexia, Blood Urea Increased, Malaise
on Sep 03, 2008 Male patient from UNITED STATES , 55 years of age, weighting 145.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin (View Usage). Patient had the following side effects: anaemia, anorexia, blood urea increased, malaise. Briplatin dosage: Also 28nov07 56.25mg/m2 1/1month. During the same period patient was treated with ALIMTA (Also 28nov07 375 Mg/m2 1/1month) (View Alimta Review and Alimta Label ), PANVITAN (Formulation = Tablet) (View Panvitan Review and Panvitan Label ), FRESMIN S (Formulation = Tablet) (View Fresmin-s Review and Fresmin-s Label ), ASTOMIN (Formulation = Tablet) (View Astomin Review and Astomin Label ), MUCODYNE (Formulation = Tablet) (View Mucodyne Review and Mucodyne Label ), PURSENNID (Formulation = Tablet) (View Pursennid Review and Pursennid Label ), PREDNISOLONE (Formulation = Tablet) (View Prednisolone Review and Prednisolone Label ), FERROMIA (Formulation = Tablet) (View Ferromia Review and Ferromia Label ).

5870192-6 | Pulmonary Infarction
on Sep 03, 2008 Male patient from JAPAN , 59 years of age, was diagnosed with metastases to liver, gastric cancer and was treated with Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: pulmonary infarction. Briplatin dosage: . During the same period patient was treated with MITOMYCIN (View Mitomycin Review and Mitomycin Label ). Patient was hospitalized.

5857402-6 | Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Bone Marrow Failure, Febrile Neutropenia, Fluid Retention, Hypercapnia, Interstitial Lung Disease, Liver Disorder
Patient was taking Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bone marrow failure, febrile neutropenia, fluid retention, hypercapnia, interstitial lung disease, liver disorder on Aug 21, 2008 from UNITED STATES Additional patient health information: Male patient , 77 years of age, weighting 132.3 lb, was diagnosed with pleural mesothelioma malignant, febrile neutropenia, bone marrow failure and. Briplatin dosage: . During the same period patient was treated with ALIMTA (View Alimta Review and Alimta Label ), PAZUCROSS (View Pazucross Review and Pazucross Label ), MEROPEN (View Meropen Review and Meropen Label ), GRAN (View Gran Review and Gran Label ), PANVITAN (View Panvitan Review and Panvitan Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), AMARYL (View Amaryl Review and Amaryl Label ), BASEN (View Basen Review and Basen Label ). Patient was hospitalized.

5857402-6 | Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Bone Marrow Failure, Febrile Neutropenia, Interstitial Lung Disease, Liver Disorder, Malignant Neoplasm Progression, Multi-organ Failure
Adverse event was reported on Aug 21, 2008 by a Male patient taking Briplatin (View Usage) (Dosage: ) was diagnosed with pleural mesothelioma malignant, febrile neutropenia, bone marrow failure and. Location: UNITED STATES , 77 years of age, weighting 132.3 lb, Patient had the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bone marrow failure, febrile neutropenia, interstitial lung disease, liver disorder, malignant neoplasm progression, multi-organ failure. During the same period patient was treated with ALIMTA (View Alimta Review and Alimta Label ), PAZUCROSS (View Pazucross Review and Pazucross Label ), MEROPEN (View Meropen Review and Meropen Label ), GRAN (View Gran Review and Gran Label ), PANVITAN (View Panvitan Review and Panvitan Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), AMARYL (View Amaryl Review and Amaryl Label ), BASEN (View Basen Review and Basen Label ). Patient was hospitalized.

5853568-2 | Anorexia, Neutropenia, Protein-losing Gastroenteropathy
on Aug 18, 2008 Female patient from JAPAN , 53 years of age, was diagnosed with lung neoplasm malignant and was treated with Briplatin (View Usage). After Briplatin was administered, patient had the following side effects: anorexia, neutropenia, protein-losing gastroenteropathy. Briplatin dosage: Cyc1:30jan08(initiated 80%) Cyc2:21feb08(80%) Cyc3:2apr08 Cyc4:30apr08. During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), NAVELBINE (Dose Taken On 30jan08 And From 21feb08 -may08) (View Navelbine Review and Navelbine Label ). Patient was hospitalized.

5850851-1 | Pulmonary Infarction
on Aug 12, 2008 Male patient from JAPAN , 59 years of age, was diagnosed with metastases to liver, gastric cancer and was treated with Briplatin (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary infarction. Briplatin dosage: . During the same period patient was treated with MITOMYCIN (View Mitomycin Review and Mitomycin Label ). Patient was hospitalized.

5849443-X | Anaemia, Anorexia, Blood Albumin Decreased, Blood Bilirubin Increased, Blood Urea Increased, Gastric Ulcer Haemorrhage, Rash, White Blood Cell Count Decreased
Patient was taking Briplatin (View Usage). Patient had the following side effects: anaemia, anorexia, blood albumin decreased, blood bilirubin increased, blood urea increased, gastric ulcer haemorrhage, rash (What is rash?), white blood cell count decreased on Aug 15, 2008 from JAPAN Additional patient health information: Male patient , 70 years of age, weighting 141.1 lb, was diagnosed with pleural mesothelioma malignant and. Briplatin dosage: . During the same period patient was treated with ALIMTA (Second Cycle Received On 16-aug-2007.third Scheduled On 09-sep-2007) (View Alimta Review and Alimta Label ), PANVITAN (View Panvitan Review and Panvitan Label ), DECADRON SRC (25-jul-2007 To 27-jul-2007; 15-aug-2007 To 17-aug-2007; 05-sep-2007 To 07-sep-2007.) (View Decadron Src Review and Decadron Src Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), KYTRIL (View Kytril Review and Kytril Label ), DAONIL (View Daonil Review and Daonil Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized and became disabled.